Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
AssigneeAmarin Corporation PLC
InventorsEli Hazum, Lior Carmon
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel uses of antisense oligonucleotides targeted to the coding region of acetylcholinesterase (AChE) for treating inflammatory disorders other than inflammatory disorders of the central nervous system or the peripheral nervous system innervating voluntary muscles. More particularly, the present invention relates to uses of antisense oligodexoynucleotides targeted to AChE mRNA for treating inflammatory disease of the gastrointestinal tract including inflammatory bowel disease.
Claims18
A method for treating an inflammatory disorder comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising as an active agent an antisense oligonucleotide targeted to ACHE mRNA and a pharmaceutically acceptable carrier, wherein the inflammatory disorder is other than an inflammatory disorder of the central nervous system or the peripheral nervous system innervating voluntary muscles.
Dependencies are inferred from the claim text.